Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Nippon Shinyaku: Hypen Drives Sales, Profits
June 2, 2008
- Exclusion of OTC-Like Drugs from Insurance Coverage May Become Issue Again: Mr Isobe
June 2, 2008
- Zeria: Sales Down 5.8% due to Disappointing Sales of Ethical Drugs
June 2, 2008
- REGULATORY NEWS IN BRIEF
May 26, 2008
- Taisho: Sales Up 4.7% for Ethical Drugs and 2.1% for Self-Medication
May 26, 2008
- R&D NEWS IN BRIEF
May 26, 2008
- Avapro Will Be 5th Strategic Product: DSP
May 26, 2008
- Use iPS Cells to Obtain Safety Data for NDA Submission
May 26, 2008
- MTPC Aims at Overseas Sales of \100 Bil. in FY2015
May 26, 2008
- Japan to Participate in Multinational PIII Study on VEGF Trap-Eye
May 26, 2008
- Eisai: First Deficit Reported due to Acquisition of MGI Pharma
May 26, 2008
- GENERICS NEWS IN BRIEF
May 26, 2008
- Daiichi Sankyo: Sales Down 5.3% due to One-time Effects of Merger
May 26, 2008
- I'rom to Market Ranbaxy's Generic Amlodipine
May 26, 2008
- Astellas: Tough Year Expected in FY2008 due to Prograf Patent Expiration
May 26, 2008
- Will Generics Take Off? (4)
May 26, 2008
- Takeda's R&D Spending to Hit Record High of \485 Bil. in FY2008
May 26, 2008
- BUSINESS NEWS IN BRIEF
May 26, 2008
- Takeda Completes Acquisition of Millennium
May 26, 2008
- Toho Pharm.: Record-High Sales and Profits
May 26, 2008
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…